Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

Gracious 1999.

Methods A patient report of atrioventricular nodal re‐entrant tachycardia during stimulant treatment
Participants Diagnosis of ADHD: DSM‐IV (subtype: not stated)
Age: 13 years old
IQ: > 70
Sex: female
Ethnicity: African American
Country: USA
Comorbidity: obsessive compulsive disorder and dysthymia
Comedication: 50 mg/day sertraline
Sociodemographics: not stated
Interventions First prescription
Methylphenidate type: not stated
Methylphenidate dosage: 30 mg
Administration schedule: twice daily: morning and noon
Duration of treatment: 3 months
Treatment compliance: noncompliant with the afternoon dose
Second prescription
Methylphenidate type: sustained release methylphenidate
Methylphenidate dosage: 20 mg
Administration schedule: once daily: morning
Duration of treatment: 11 months
Treatment compliance: intermittently compliant
Outcomes First prescription
No serious or non‐serious adverse events reported
Second prescription
Serious adverse events:
After 5 months of treatment; 2 15‐minute episodes of chest pain, associated with tingling in her fingers and shortness of breath. Heart rate: 96. Blood pressure: 155/79. 1 month later chest pain, shortness of breath, sweating, and palpitations beginning during urination. Heart rate: 100
No cardiac complaints in the following 5 months
Notes Funding/vested interests: none
Authors' affiliations: Division of Child Psychiatry, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio
Key conclusions of the study authors: stimulant medication may evoke onset of atrioventricular nodal tachyarrhythmias in patients who have the potential to develop them, possibly in combination with a selective serotonergic reuptake inhibitor
Comments from the study authors: the cardiologist consulted believed this patient had a structural vulnerability of genetic etiology for the arrhythmia which was then precipitated by the stimulant
Supplemental information regarding ADHD diagnostic criteria and IQ received through personal email correspondence with the authors in October 2013 (Gracious 2013 [pers comm])